Etheros Pharmaceuticals
Etheros Pharmaceuticals is a startup headquartered in Nashville, United States, founded in 2022. It has raised at least $1.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Etheros Pharmaceuticals has raised at least $1.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Etheros Pharmaceuticals sits inside the Nashville R&D ecosystem in the Global R&D Labs Directory.
Other startups in Nashville
- Agyl Ai
- AngelEye Health
- Augment Health
- Big B
- BuildWitt
- Bunches
- Elysian Insurance Services
- Fabtek Investments
- Fifr
- Homeware
- Live Cyber Holdings
Related
- Innovation profile of Nashville
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Etheros Pharmaceuticals do?
Etheros Pharmaceuticals is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Etheros Pharmaceuticals raised?
At least $1.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Etheros Pharmaceuticals based?
Etheros Pharmaceuticals is headquartered in Nashville, United States.
When was Etheros Pharmaceuticals founded?
Etheros Pharmaceuticals was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.